1. Multiple False-positive Serologic Tests for HIV, HTLV-1, and Hepatitis C Following Influenza Vaccination, 1991
2. Ministry of Health and Welfare. Blood management act enforcement regulation. http://www.law.go.kr/lsInfoP.do?lsiSeq=167324&efYd=20150112#0000 [Online] last visited on 5 October 2016
3. U.S. Food and Drug Administration. Guidance for industry:nucleic acid testing (NAT) for human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV):testing, product disposition, and donor deferral and reentry. http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Blood/UCM210270.pdf [Online] last visited on 5 October 2016
4. Canadian Blood Services. Donor reentry at Canadian Blood Services. http://www.transfusionmedicine.ca/sites/transfusionmedicine/files/events/Donor%20Re-Entry%20Slides%202014-11-04.pdf [Online] last visited on 21 January 2016
5. U.S. Food and Drug Administration. FDA memorandum to all registered blood establishments:“revised recommendations for the prevention of Human Immunodeficiency Virus (HIV-1) transmission by blood and blood products.”. http://www.fda.gov/downloads/BiologicsBloodVaccines/Guidance [Online] last visited on 19 September 2016